Ja. Plumb et P. Workman, UNUSUALLY MARKED HYPOXIC SENSITIZATION TO INDOLOQUINONE EO9 AND MITOMYCIN-C IN A HUMAN COLON-TUMOR CELL-LINE THAT LACKS DT-DIAPHORASE ACTIVITY, International journal of cancer, 56(1), 1994, pp. 134-139
Studies with purified DT-diaphorase have shown that the enzyme is capa
ble of catalyzing a two-electron reduction of the novel indoloquinone
EO9 to a DNA-damaging alkylating species. The aim of this study war to
determine to what extent DT-diaphorase may be involved in the metabol
ic activation of EO9 and mitomycin C in both aerobic and hypoxic condi
tions. Two human colon-carcinoma cell lines were used; HT29 has high l
evels of DT-diaphorase whilst BE lacks this activity because of a poin
t mutation in the NQOI gene. In aerobic conditions the 2 cell lines sh
ow similar sensitivities to a number of cytotoxic drugs including cisp
latin, doxorubicin and etoposide. They are equally sensitive to the be
nzotriazine di-N-oxide SR 4233 but HT29 is more sensitive than BE to m
itomycin C and EO9. Sensitivity to SR 4233 is increased by about 100-f
old for both cell lines in hypoxic conditions. DT-diaphorase-deficient
BE cells show markedly increased sensitivity to mitomycin C and parti
cularly EO9 in hypoxic conditions, whereas DT-diaphorase-rich HT29 cel
ls show little hypoxic sensitization to these agents unless exposed in
the presence of dicoumarol. These results suggest that DT-diaphorase
can reduce EO9 and mitomycin C to potent cytotoxic species in aerobic
conditions, and this activity predominates over the one-electron-reduc
ing enzymes even in hypoxic conditions. In the absence of DT-diaphoras
e activity, EO9 and mitomycin C are reduced in hypoxic conditions, pre
sumably by one-electron-reducing enzymes, to a similar or greater exte
nt than is achieved with DT-diaphorase. (C) 1994 Wiley-Liss, Inc.